PROLOR Biotech, Inc. Common Stock
PBTH
PBTH was delisted on the 29th of August, 2013.
0 hedge funds and large institutions have $0 invested in PROLOR Biotech, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.
100% less funds holding
Funds holding: 3 → 0 (-3)
100% less capital invested
Capital invested by funds: $4.79M → $0 (-$4.79M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$4.6M |
| 2 |
CDH
Charles D. Hyman
|
-$173K |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$19K |
PBTH Hedge Fund Activity: Q4 2013 in Review
0 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in PROLOR Biotech, Inc. Common Stock (PBTH) for Q4 2013, worth a combined $0 — down 100% from $4.79M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PBTH and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Group One Trading, exiting entirely with an estimated $4.6M sold.
- 0 institutional investors held PROLOR Biotech, Inc. Common Stock (PBTH) as of Q4 2013, down from 3 in Q3 2013.
- Funds reported $0 of PROLOR Biotech, Inc. Common Stock stock for Q4 2013, down 100% quarter-over-quarter.
- 0 funds opened new PROLOR Biotech, Inc. Common Stock positions in Q4 2013 and 3 closed out, a net change of -3 holders.
- The largest PROLOR Biotech, Inc. Common Stock seller in Q4 2013 was Group One Trading, an estimated $4.6M sold.
Based on aggregated 13F filings for Q4 2013.